Preventing Negative Reactions in First Time Blood Donors to Encourage Subsequent Blood Donations

NCT ID: NCT00302900

Last Updated: 2016-10-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

441 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-01-31

Study Completion Date

2010-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Many individuals experience negative reactions when donating blood, including dizziness, lightheadedness, or fainting. Such reactions may discourage them from donating again. This study will evaluate the effectiveness of pre-donation water consumption and a muscle tensing exercise during donation to reduce negative reactions among new blood donors. This study will also evaluate whether reducing negative reactions increases the likelihood of donors returning to give blood in the future.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Severe and potentially dangerous shortages in the blood supply are increasingly common in the United States. As the population ages and as more stringent donor eligibility restrictions are enforced, blood shortages are expected to worsen. One way to meet the increasing demand for blood is to recruit new blood donors. Ideally, these individuals would become lifelong donors, and contribute up to six times per year and up to hundreds of units of blood within a lifetime. Unfortunately, less than half of all new donors provide a second donation. Many individuals who donate blood experience dizziness, weakness, lightheadedness, or in severe cases, fainting. As a result of these negative reactions, many individuals never donate blood again. Preventing these reactions may be an effective way to encourage subsequent blood donations. The purpose of this study is to evaluate the effectiveness of consuming water prior to donation and performing a muscle tensing exercise during donation as ways to reduce negative reactions in new blood donors. The study's long-term goal is to provide blood collection agencies with simple and inexpensive strategies to prevent negative reactions and enhance donor retention.

This study will enroll American Red Cross blood donors who have donated blood no more than twice previously. Participants will be randomly assigned to one of the following four groups: 1) pre-donation water consumption and muscle tensing exercise during donation; 2) pre-donation water consumption; 3) pre-donation muscle tensing exercise; or 4) no treatment. Participant reactions will be assessed at the time of donation by self-report and phlebotomist ratings, as well as by self-report 24 hours following the donation. Participants' subsequent donation history will be tracked for two years by reviewing the American Red Cross national donor database.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Syncope, Vasovagal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Pre-donation water and muscle tension during donation

Group Type EXPERIMENTAL

Pre-Donation Water Consumption

Intervention Type BEHAVIORAL

Consumption of 500 ml of bottled water 30 minutes prior to donating

Muscle Tensing Exercise During Donation

Intervention Type BEHAVIORAL

Alternating leg lifts at 10-second intervals during donation

2

Pre-donation water

Group Type EXPERIMENTAL

Pre-Donation Water Consumption

Intervention Type BEHAVIORAL

Consumption of 500 ml of bottled water 30 minutes prior to donating

3

Pre-donation muscle tension

Group Type SHAM_COMPARATOR

Muscle Tensing Exercise Prior to Donation

Intervention Type BEHAVIORAL

Alternating leg lifts at 10-second intervals prior to insertion of the donation needle

4

Standard donation

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pre-Donation Water Consumption

Consumption of 500 ml of bottled water 30 minutes prior to donating

Intervention Type BEHAVIORAL

Muscle Tensing Exercise During Donation

Alternating leg lifts at 10-second intervals during donation

Intervention Type BEHAVIORAL

Muscle Tensing Exercise Prior to Donation

Alternating leg lifts at 10-second intervals prior to insertion of the donation needle

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must meet American Red Cross donor eligibility requirements

Exclusion Criteria

* No more than two prior blood donations
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

Ohio University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christopher R. France, PhD

Role: PRINCIPAL_INVESTIGATOR

Ohio University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ohio University

Athens, Ohio, United States

Site Status

American Red Cross Blood Services - Central Ohio Region

Columbus, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01HL077438

Identifier Type: NIH

Identifier Source: secondary_id

View Link

371

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mechanisms of Vasovagal Syncope
NCT01791816 COMPLETED EARLY_PHASE1
Magnesium Sulfate For Brain Injury
NCT00004730 COMPLETED PHASE3
Inhaled Nitric Oxide in Brain Injury
NCT03260569 COMPLETED PHASE3